ストックスクリーナーアプリを入手
29.44
0.47%
-0.14
アフターアワーズ：
29.42
-0.02
-0.07%
Pfizer Inc (PFE) 最新ニュース
Migraine Market is Expected to Expand at 6% Growth Rate by 2036, Owing to the Development of Novel Mechanisms beyond CGRP, including PACAP-targeted Therapies, TRPA1 Antagonists, and Next-generation Neuromuscular Approaches | DelveInsight - GlobeNewswire Inc.
Pfizer's Non-Oncology Performance in Q3: Driving Factors to Watch - Zacks Investment Research
Can Lifyorli Aid Corcept's Long-Term Growth Prospects Beyond Korlym? - Zacks Investment Research
Is Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) a Strong ETF Right Now? - Zacks Investment Research
Key facts: Pfizer Inc. expands oncology tie-up; raises dividend $0.43 - TradingView
Can Pfizer’s (NYSE:PFE) Earnings Support Its NYSE Composite Position? - Kalkine Media
Another BioNTech Cancer Vaccine Just Hit a Major Setback. Is BNTX Stock Still a Buy? - The Motley Fool
Here's What $10,000 in Each of These 5 High-Yield Dividend Stocks Could Pay You in a Year - The Motley Fool
Micro Pfizer Inc Stock Futures, (XPFE0H27.CME) interactive stock chart - Yahoo Finance UK
Micro Pfizer Inc Stock Futures, (XPFE0H27.CME) latest stock news and headlines - Yahoo Finance UK
Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer Pipeline - The Motley Fool
PFIZER INC (PFE-USD.SW) cash flow - Yahoo Finance UK
Bristol-Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Pfizer Inc. (PFE.TO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Here's How Many Shares of AbbVie You'd Need for $5,000 in Yearly Dividends - The Motley Fool
Pfizer Just Declared Its 352nd Straight Quarterly Dividend. Is the 6% Yield Safe? - The Motley Fool
Johnson & Johnson: 3 Key Takeaways for Long-Term Investors - The Motley Fool
Pfizer vs. AbbVie: Is the Cheaper Pharma Stock Really the Better Investment? - Yahoo Finance
What to Expect From Pfizer's Q3 2026 Earnings Report - Yahoo Finance
Lilly, Pfizer, J&J win EU drug recommendations this month - Seeking Alpha
PFIZER INC. R (PFE.DE) Q1 FY2025 earnings call transcript - Yahoo Finance
Layoffs Tracker: Kroger, Pfizer, Netflix and Amazon Hit This Week - Yahoo Finance
6 Blue Chip Stocks Trading Well Below Their Highs - The Motley Fool
Pfizer Inc. (PFE) latest press releases and corporate news - Yahoo Finance Australia
2 High-Yield Dividend Stocks Worth Buying Before 2026 Ends - The Motley Fool
Obesity Clinical Trial and Competitive Landscape Surges as 200+ Companies Advance Next-Generation Therapies | DelveInsight - GlobeNewswire Inc.
Pfizer Stock Hits 52-Week High: What's Going On? - Benzinga
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Pfizer stock hits 52-week high at $29.88 - Investing.com
The Pfizer Foundation and the American Red Cross: Strengthening Communities Year-Round - American Red Cross
Pfizer, Thermo Fisher Scientific And More: CNBC’s ‘Final Trades’ - Benzinga
PFIZER INC (PFE-USD.SW) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Pfizer Inc (Coinbase Tokenized Stock) Price | PFEc Price Today, Live Chart, USD converter, Market Capitalization - CryptoRank
Pfizer (NYSE:PFE): What Changes After Its Latest Company Update? - Kalkine Media
Pfizer (PFE) Gains As Market Dips: What You Should Know - Zacks Investment Research
Pfizer (PFE) Gains As Market Dips: What You Should Know - Yahoo Finance
Micro Pfizer Inc Stock Futures, (XPFE0Z26.CME) Stock Historical Prices & DataYahoo Finance - Yahoo! Finance Canada
Micro Pfizer Inc Stock Futures, (XPFE0Z26.CME) latest stock news and headlines - Yahoo Finance UK
Pfizer Inc Stock (PFE) Moved Up by 3.14% on Oct 14: Drivers Behind the Movement - TradingKey
Pfizer cuts another 150 jobs at Portage plant as demand slips - Crain's Grand Rapids Business
Pfizer’s Next‑Gen Pneumococcal Shot Enters Key Phase 3 Test, Extending Vaccine Growth Potential - TipRanks
Pfizer Showcases Clinical Advancements Across Infectious Diseases at IDWeek 2026 - Business Wire
Pfizer partners with Enodia Therapeutics in $500m drug deal - Pharmaceutical Technology
PFEPfizer, Inc. | News - OTC Markets
Pfizer (PFE) Pays Out Over 226% of Earnings and Trades at 36.7x Trailing Against 9.8 Forward. What Is the Yield Telling You? - Yahoo Finance
MRNA Stock Gains Over $4B in a Week: Time to Buy, Hold or Sell? - Zacks Investment Research
Reasons Why Investors Should Consider Betting on Arvinas Stock - Zacks Investment Research
Enodia Therapeutics Announces Research Collaboration and License Agreement with Pfizer to Develop Sec61-Targeting Small Molecules - BioSpace
Pfizer: The Earnings Test That Matters (NYSE:PFE) - Seeking Alpha
Guggenheim reiterates Pfizer stock rating ahead of Q3 earnings - Investing.com
1.06%
大文字化:
|
ボリューム (24 時間):